Skip to content
Cytognomix Logo
We find and validate mutations that others cannot
  • Home
  • Mission
    • Challenges in genomics: our solutions
  • Products
    • Biodosimetry: Automated Dicentric Chromosome Identifier
      • Testing for Radiation Exposure
    • Mutation Forecaster®
      • Interpretation of mutations in next generation sequencing data: Shannon pipeline
        • Testimonials for the Shannon pipeline
      • Automated Splice Site and Exon Definition Server (ASSEDA)
        • Publications
      • Software for validation of predicted mRNA splicing mutations
        • Testimonials for Veridical
      • Cytognomix User Variation Database (CUVD)
    • Solution capture pools for targeted deep sequencing
    • Targeted array CGH
    • Single copy FISH
      • Customized scFISH probes
      • Standard SC-FISH probes
      • Subtelomeric SC-FISH probes Catalog
    • Product advantages
    • Product Gallery
  • Posts
  • Purchase
    • Pricing
  • Contact Us
  • About us
    • Intellectual Property
    • Applications
  • Resources
  • SiteMap
  • Menu

January 11, 2019. Article on Prediction of platin chemotherapy response now available

Posted on January 12, 2019January 12, 2019 by Peter Rogan
Our paper: “Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning” has been pulbished in the journal Signal Transduction and Targeted Therapy.
 
The article is open access. Here is a link to the paper:  https://rdcu.be/bgaGR
Written by: Peter Rogan on January 12, 2019.
Posted in News.

Post navigation

← December 14. New paper published…
January 9, 2019. Article on… →

Recent Posts

  • March 25, 2025. Videos available about radiation biology.
  • January 25, 2024. Appreciation of Cytognomix’s COVID-19 research studies by the government of Ontario
  • Oct. 4, 2023. Radiobiology textbook published
  • Sept. 19, 2023. Democratizing ADCI as cloud-based software
A SiteOrigin Theme